How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Quest Intl., Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
25 clearance records and 0 recall records in the covered releases, across 1 source company names and 16 product codes. Dated history runs from Apr 6, 1989 to Jun 8, 2009.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| SERAQUEST EBV EA-D IGG TESTK091260 · LSE | Quest Intl., Inc. | 510(k) | Jun 8, 2009FDA decision date |
| MODIFICATION TO SERAQUEST EB VCA IGGK033915 · LSE | Quest Intl., Inc. | 510(k) | Jan 16, 2004FDA decision date |
| MODIFICATION TO SERAQUEST VCA IGMK033780 · LJN | Quest Intl., Inc. | 510(k) | Jan 15, 2004FDA decision date |
| SERAQUEST ANTI-THYROID PEROXIDASE (TPO)K023593 · JZO | Quest Intl., Inc. | 510(k) | Feb 6, 2003FDA decision date |
| SERAQUEST ANTI-THYROGLOBULINK023592 · DDC | Quest Intl., Inc. | 510(k) | Jan 6, 2003FDA decision date |
| ANTI-CARDIOLIPIN, MULTIPLE AUTOANTIBODIES IMMUNOLOGICAL TEST SYSTEMK003069 · MID | Quest Intl., Inc. | 510(k) | Nov 27, 2000FDA decision date |
| SERAQUEST EB NA IGGK991975 · LSE | Quest Intl., Inc. | 510(k) | Nov 2, 1999FDA decision date |
| SERAQUEST EB VCA IGGK990410 · LSE | Quest Intl., Inc. | 510(k) | Oct 28, 1999FDA decision date |
| SERAQUEST EB VAC IGMK990977 · LJN | Quest Intl., Inc. | 510(k) | Oct 6, 1999FDA decision date |
| SERAQUEST CMV IGMK982485 · LFZ | Quest Intl., Inc. | 510(k) | Jan 13, 1999FDA decision date |
| SERAQUEST RUBELLA IGMK982281 · LFX | Quest Intl., Inc. | 510(k) | Oct 16, 1998FDA decision date |
| SERAQUEST ANTI-SMK980540 · LKP | Quest Intl., Inc. | 510(k) | Jun 15, 1998FDA decision date |
| SERAQUEST ANTI-SSBK980639 · LLL | Quest Intl., Inc. | 510(k) | Jun 15, 1998FDA decision date |
| SERAQUEST ANTI-SSAK980810 · LJM | Quest Intl., Inc. | 510(k) | May 12, 1998FDA decision date |
| SERAQUEST ANTI-SM/RNPK980811 · LKP | Quest Intl., Inc. | 510(k) | May 12, 1998FDA decision date |
| SERAQUEST ANTI-DSDNAK980391 · LRM | Quest Intl., Inc. | 510(k) | Apr 24, 1998FDA decision date |
| SERAQUEST MUMPS IGGK980059 · LJY | Quest Intl., Inc. | 510(k) | Apr 23, 1998FDA decision date |
| SERAQUEST VZV IGGK972295 · LFY | Quest Intl., Inc. | 510(k) | Nov 5, 1997FDA decision date |
| SERAQUEST TOXOPLASMA IGMK971672 · LGD | Quest Intl., Inc. | 510(k) | Oct 21, 1997FDA decision date |
| SERAQUEST HSV IGGK963282 · LGC | Quest Intl., Inc. | 510(k) | Jan 22, 1997FDA decision date |
| SERAQUEST RUBELLA IGGK961053 · LFX | Quest Intl., Inc. | 510(k) | Sep 4, 1996FDA decision date |
| SERAQUEST TOXOPLASMA IGGK960092 · LGD | Quest Intl., Inc. | 510(k) | Jun 17, 1996FDA decision date |
| SERAQUEST CMV IGGK954191 · LFZ | Quest Intl., Inc. | 510(k) | Feb 23, 1996FDA decision date |
| PATIENT EXAMINATION GLOVES (LATEX)K891736 · LYY | Quest Intl., Inc. | 510(k) | May 25, 1989FDA decision date |
| LATEX EXAMINATION GLOVES NON-STERILEK890356 · LYY | Quest Intl., Inc. | 510(k) | Apr 6, 1989FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.